Brighton Jones »

Oncternal Therapeutics shares owned by Brighton Jones

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by Brighton Jones from 13F filings

Historical chart of Brighton Jones investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Brighton Jones consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Brighton Jones

Quarter filed Position value Share count Share price at filing
2024-06-30 $129k 17k 7.60
2024-03-31 $152k 17k 9.00

More positions owned by Brighton Jones

Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Rus 1000 Etf (IWB)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Global Real Est (DFGR)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Manager Directed Portfolios Vert Glb Sust Re (VGSR)
Metropcs Communications (TMUS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)

View all positions for Brighton Jones

Top funds holding Oncternal Therapeutics

Vanguard Group
Millennium Management
BlackRock
Dimensional Fund Advisors
Geode Capital Management
Pasadena Private Wealth
Richmond Brothers
Renaissance Technologies
Susquehanna International
Morgan Stanley
Quantum Private Wealth
Acadian Asset Management
Jpmorgan Chase & Co
Tower Research Capital
Wells Fargo & Company

View all funds holding Oncternal Therapeutics